2022 US Medicinal Products

Financial Strength Rankings using Artificial Intelligence

Top rated12 of 50
Best rating299 %
Worst rating-7,995 %
New companies8
Negative Economic Capital Ratio24 of 50

Charlie’s Holdings Inc. climbed 44 positions from 45 to 1 due it’s excellent Net Income. Cronos Group Inc. lost 18 positions from 10 to 28 due it’s bad Revenues. Alpha Teknova Inc. entered the 2022 ranking at rank 14, making it the best newcomer.

Revenues42.1 B
Assets67.5 B
Expenses40.5 B
Stockholders Equity33.4 B
Unprofitable companies32 of 50

2. NEOGEN CORP

237.70%

5. INNOSPEC INC.

184.20%

7. BALCHEM CORP

175.64%

9. FMC CORP

151.53%

10. Huntsman CORP

135.93%

11. MANNATECH INC

128.88%

13. IMMUCELL CORP DE

126.05%

14. Alpha Teknova Inc.

124.02%

15. OLIN Corp

119.47%

16. HESKA CORP

118.15%

17. MYRIAD GENETICS INC

113.34%

18. Livent Corp.

109.55%

20. CYANOTECH CORP

100.55%

23. Ingevity Corp

58.05%

24. Chemours Co

50.64%

26. Ecovyst Inc.

18.36%

27. Target Group Inc.

-7.99%

28. Cronos Group Inc.

-17.63%

30. Canopy Growth Corp

-69.18%

31. ARCA biopharma Inc.

-75.84%

32. Oncocyte Corp

-148.42%

33. Hanjiao Group Inc.

-148.73%

34. ChromaDex Corp.

-179.24%

35. Quotient Ltd

-202.82%

36. BLOOMIOS INC.

-206.43%

37. BIOMERICA INC

-223.88%

43. Loop Industries Inc.

-410.05%

44. VOLITIONRX LTD

-483.56%

46. Stem Holdings Inc.

-560.61%

47. NUTRA PHARMA CORP

-678.62%

United States Ratings

German Insurance Ratings